"The relationships between the host and its microbiota are still poorly appreciated, notably in liver diseases. NovoBiome will open up new and highly impactful perspectives in terms of diagnosis, as well as preventive and therapeutic strategies targeting liver diseases along with the implementation an outstanding platform that mimics human intestinal physiology."

Joel Doré
Research Director at INRAE